NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
40.45
Dollar change
+0.91
Percentage change
2.30
%
IndexRUT P/E- EPS (ttm)-2.61 Insider Own19.13% Shs Outstand9.60M Perf Week4.28%
Market Cap451.08M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float9.02M Perf Month13.69%
Enterprise Value441.01M PEG- EPS next Q- Inst Own64.75% Short Float28.86% Perf Quarter9.24%
Income-29.88M P/S9.16 EPS this Y- Inst Trans36.57% Short Ratio2.69 Perf Half Y-28.06%
Sales49.23M P/B2.40 EPS next Y- ROA-15.84% Short Interest2.60M Perf YTD-25.09%
Book/sh16.85 P/C44.57 EPS next 5Y- ROE-24.94% 52W High81.56 -50.40% Perf Year19.89%
Cash/sh0.91 P/FCF27.01 EPS past 3/5Y34.29% 22.23% ROIC-18.48% 52W Low21.77 85.81% Perf 3Y38.39%
Dividend Est.- EV/EBITDA33.51 Sales past 3/5Y2.01% 11.43% Gross Margin90.96% Volatility6.50% 8.87% Perf 5Y-13.90%
Dividend TTM- EV/Sales8.96 EPS Y/Y TTM-172.20% Oper. Margin25.61% ATR (14)3.43 Perf 10Y1378.44%
Dividend Ex-Date- Quick Ratio0.51 Sales Y/Y TTM-25.28% Profit Margin-60.69% RSI (14)57.20 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.52 EPS Q/Q-963.99% SMA2014.49% Beta1.35 Target Price71.00
Payout0.00% Debt/Eq0.00 Sales Q/Q-44.44% SMA5011.07% Rel Volume0.31 Prev Close39.54
Employees79 LT Debt/Eq0.00 EarningsMay 13 AMC SMA200-2.98% Avg Volume968.14K Price40.45
IPOFeb 21, 2014 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume298,843 Change2.30%
Date Action Analyst Rating Change Price Target Change
Nov-02-22Downgrade B. Riley Securities Buy → Neutral $60 → $45
Jul-02-25 07:56AM
Jun-26-25 05:00AM
Jun-24-25 11:37AM
08:00AM
Jun-20-25 01:12PM
12:00AM Loading…
12:00AM
Jun-19-25 04:45PM
Jun-05-25 09:49PM
May-30-25 11:11AM
May-19-25 09:11AM
08:00AM
May-13-25 04:01PM
Apr-30-25 08:00AM
Apr-25-25 08:00AM
Apr-23-25 08:44AM
02:56PM Loading…
Apr-22-25 02:56PM
Apr-07-25 07:04PM
Apr-05-25 11:00AM
Mar-20-25 09:16AM
Feb-19-25 02:05AM
Feb-18-25 04:01PM
Feb-04-25 08:00AM
Jan-24-25 07:00AM
Jan-23-25 04:02PM
04:01PM
Jan-13-25 08:00AM
Dec-16-24 08:05AM
Dec-05-24 08:00AM
Nov-26-24 02:03PM
Nov-25-24 07:00AM
04:21PM Loading…
Nov-21-24 04:21PM
Nov-18-24 12:19PM
08:00AM
Nov-05-24 11:50PM
08:00AM
Nov-04-24 04:01PM
Oct-21-24 04:01PM
Aug-26-24 08:03AM
Aug-12-24 10:18AM
Aug-05-24 08:59PM
04:01PM
Jul-22-24 04:05PM
Jun-10-24 05:32PM
Jun-06-24 04:58PM
May-28-24 09:03AM
May-23-24 05:42AM
May-08-24 11:17AM
May-07-24 09:57PM
06:25PM
04:01PM
Apr-23-24 08:03AM
Mar-07-24 01:57PM
09:38AM
Mar-05-24 08:51PM
04:01PM
Feb-21-24 08:03AM
Feb-19-24 11:14AM
Nov-11-23 10:48AM
Nov-09-23 04:01PM
Oct-26-23 04:01PM
Sep-14-23 01:08PM
Aug-31-23 04:01PM
Aug-10-23 04:01PM
Jul-28-23 08:03AM
Jul-11-23 08:03AM
Jun-23-23 04:01PM
May-10-23 04:01PM
May-01-23 04:01PM
Apr-28-23 04:01PM
Apr-19-23 04:01PM
Apr-05-23 08:03AM
Apr-03-23 08:01AM
Mar-21-23 04:05PM
04:01PM
Mar-10-23 08:03AM
Mar-01-23 04:01PM
Dec-14-22 08:03AM
Dec-12-22 08:05AM
Nov-01-22 04:01PM
Oct-19-22 04:01PM
Aug-31-22 08:03AM
Aug-16-22 06:35AM
Aug-02-22 04:01PM
Jul-21-22 08:03AM
Jun-30-22 07:48AM
May-23-22 10:31AM
May-05-22 10:10AM
May-02-22 07:15PM
04:01PM
Apr-19-22 08:03AM
Apr-07-22 08:03AM
Mar-30-22 03:43PM
Mar-14-22 04:01PM
Mar-01-22 08:01AM
Feb-28-22 04:01PM
12:38PM
Feb-17-22 08:03AM
Jan-25-22 05:38PM
Jan-21-22 08:59AM
Jan-19-22 09:38AM
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers' patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Campbell, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEMLER ERICDirectorJun 11 '25Option Exercise23.326,750157,410636,346Jun 12 06:01 AM
Cormier RenaeChief Financial OfficerJun 11 '25Option Exercise30.483,746114,1783,746Jun 12 06:01 AM
SEMLER ERICDirectorDec 16 '24Option Exercise23.327,875183,645629,596Dec 17 04:15 PM
Murphy-Chutorian DouglasCEODec 10 '24Option Exercise3.44140,083481,886140,083Dec 12 04:15 PM
Murphy-Chutorian DouglasCEODec 11 '24Option Exercise3.4414,91751,31480,000Dec 12 04:15 PM
Murphy-Chutorian DouglasCEODec 10 '24Sale60.1275,0004,508,68365,083Dec 12 04:15 PM
Murphy-Chutorian DouglasCEODec 11 '24Sale62.2425,0001,556,12355,000Dec 12 04:15 PM
Douglas Murphy-ChutorianCEODec 10 '24Proposed Sale62.00100,0006,200,000Dec 09 04:05 PM
Chang William HDirectorDec 09 '24Proposed Sale61.7510,000617,500Dec 09 02:11 PM
Murphy-Chutorian DouglasCEONov 07 '24Option Exercise2.33100,000233,000100,000Nov 12 06:06 AM
Murphy-Chutorian DouglasCEONov 07 '24Sale37.9350,0001,896,50050,000Nov 12 06:06 AM
SEMLER ERICDirectorNov 07 '24Buy37.9350,0001,896,500621,721Nov 12 06:05 AM
Murphy-Chutorian DouglasCEOAug 29 '24Sale28.3510,000283,45360,220Aug 30 06:11 PM
Murphy-Chutorian DouglasCEOAug 28 '24Sale28.3278022,08770,220Aug 30 06:11 PM
DOUGLAS MURPHY-CHUTORIANOFFICERAug 29 '24Proposed Sale28.3510,000283,453Aug 29 07:54 PM
DOUGLAS MURPHY-CHUTORIANOFFICERAug 28 '24Proposed Sale28.3278022,087Aug 29 07:53 PM
Murphy-Chutorian DouglasCEOAug 26 '24Option Exercise2.1071,000149,10071,000Aug 27 04:50 PM